Home > Healthcare & Medical Devices > Animal Diagnostics Market

Animal Diagnostics Market Size By Technology [Immunodiagnostics {ELISA, Lateral Flow Assays, Immunoassay Analyzers}, Clinical Biochemistry, Hematology, Molecular Diagnostics {PCR, Microarrays}, Urinalysis], By Animal Type [Farm Animals {Poultry, Swine, Cattle}, Companion Animals {Dogs, Cats, Horses}], COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI2495
  • Published Date: Jul 2021
  • Report Format: PDF

Industry Trends

Animal Diagnostics Market size was valued at over USD 4.5 billion in 2020 and is expected to grow at a CAGR of 8.5% from 2021 to 2027.

Get more details on this report - Request Free Sample PDF

Rising adoption of pets and increasing number of pets across the globe has promoted the demand for animal care products such as veterinary medications, vaccines and diagnostics among others. Growing incidence of zoonotic and infectious diseases, increasing animal health expenditure and rising number of veterinary practitioners are stimulating the market growth. Additionally, growing demand for livestock animals for meat products, animal protein and large-scale animal farming is further projected to expedite the market expansion during the forecast period.

Animal diagnostics refers to various tools used in diagnosis of animal diseases caused due to microorganisms such as bacteria, viruses, pathogens and fungi among others. Veterinarians implement these animal diagnostics tools to detect the disease, monitor the disease progression and offer optimal therapeutics, and check the presence of disease-causing agents in healthy animals. Animal diagnostics kits provide quick, sensitive, specific, & cost-effective diagnosis and a wide array of these tests is available that finds application against several animal diseases.

However, high cost associated with animal diagnostics may render a negative impact on the market progression. These diagnostic tests are expensive as they need staff, instruments, overheads, and laboratory expenses to process them. Veterinary costs are also competitive based on the nature of the services offered, pet’s weight and size that influence the costs for services rendered. As pet owners are comparatively more concerned about their pet’s health and nutrition, they tend to invest in pet healthcare services & products to provide quality care. Furthermore, the USDA, Center for Veterinary Biologics, and APHIS have implemented the Virus Serum-Toxin Act to ensure safe and effective distribution of veterinary biologics for prevention, diagnosis, and treatment of animal diseases in the country.

The animal diagnostics kits used in the detection of pathogens are classified as under veterinary biologics by the United States Department of Agriculture– Animal and Plant Health Inspection Service (USDA-APHIS). The regulations for these diagnostic kits are regulated by the USDA’s Center for Veterinary Biologics (USDA-CVB). The U.S. Department of Agriculture maintains a complex approval process involving manufacturing process inspections and other time-consuming tasks for animal diagnostics kits. The prolonged approval procedure creates a burden on market players as well as extends the time required for introducing a new product in the market. Thus, rigid regulatory framework and time-consuming market approvals may slow down the industry growth.


The animal diagnostics market has been impacted attributed to the COVID-19 pandemic and the slender effects of the coronavirus outbreak may continue in the near future. The impact of COVID-19 peaked during 2020 wherein, the customers opted for animal diagnostics test kits for ensuring the well-being of the owned animals. The SARS-CoV-2 pandemic drastically changed and hampered the operations of animal diagnostics laboratories. Lockdown events have compelled several veterinary practices to remain closed for weeks. Other challenges such as interrupted delivery services, hindrance in diagnostic testing, changed protocols related to the handling of highly infectious samples, among others have impeded the industry expansion. As a result, the market witnessed a slow growth in early 2020. However, several incidents reported infection of the zoo as well as domestic animals due to coronavirus.

Growing pet adoption is anticipated to augment the animal diagnostics market value

Rising pet adoption coupled with increasing disposable income spent significantly on pet healthcare is slated to promote the industry progression. There has been a steady rise in the pet adoption rate in the last few years. For instance, as per the American Pet Products Association (APPA), the total number of cats, dogs, and horses adopted in the U.S. increased from 172.5 million in 2011-2012 to 191.5 million in 2017-2018. Moreover, as per the European Pet Food Industry Statistics, about 80 million households across the European Union owned at least one pet. The rising usage of pets in ad campaigns and films has fueled the conviction of pet adoption among the overall population. There has been a change in drift from pet owners to pet parents that displays pets are considered as a part of the family nowadays. Pets are largely adopted in developed countries such as the U.S. and Europe majorly by elderly people for companionship.

According to the European Pet Food Industry Federation (FEDIAF) article published in 2019, cats continue to be the most popular pet in the European household with a population of around 77.4 million in the European Union and over 106.4 million in Europe and Russia. In addition, the popularity of dogs across the region has upsurge significantly with approximately 68.5 million dogs in the European Union and over 87.5 million in Europe and Russia in 2019. The surging societal acceptance of pet animals has propelled pet adoption. Adult pets are considered to be the perfect companion for elderly people as they do not need exceptional nutrition and care. Pet adoption is also perceived to aid in depression, loneliness, and low blood pressure.

Technological advancements in clinical biochemistry stimulating the market revenue

The clinical biochemistry segment in the animal diagnostics market captured around USD 1.35 billion in 2020 led by the growing application of several diagnostic & therapeutic tools to monitor the occurrence of animal diseases and technological advancements in clinical biochemistry. Rising incidence of infectious animal diseases is further poised to surge the demand for animal diagnostics. Advancements in diagnostics coupled with the increasing acceptance of advanced techniques in the majority of the laboratories are driving the segment growth. For instance, development of immunoassay technique for the assay of insulin and the immunobinding approach offers high precision in the presence of low hormone levels. The emergence of Point of Care Testing (POCT) instruments that are capable of assessing parameters as well as incorporating clinical information to provide accurate diagnostics and insights that aid in decision making. The POCT instruments are highly used in mobile veterinary units.

High adoption of companion animals and pets for companionship is predicted to facilitate the market demand

Get more details on this report - Request Free Sample PDF


The companion animals segment dominated more than 60% of the animal diagnostics market share in 2020 on account of the rising usage of pets for companionships, large population of pet cats & dogs, and surging demand for pet care products. As per the European Pet Food Industry Federation (FEDIAF) in 2020, the dog population was over 89 million, and the cat population was over 110 million in Europe. Similarly, Australia has one of the highest pet ownership rates with around 61% households in the country own pets. The total number of companion animals is Australia is around 29 million. The COVID-19 pandemic resulted in higher pet adoption as compared to previous years and the acceptance rate soared amidst lockdowns and travel restrictions.

High product acceptance in the North America region to curb the disease burden will promote the regional growth

Get more details on this report - Request Free Sample PDF


U.S. dominated the North America animal diagnostics market and is estimated to reach USD 3.75 billion by 2027 owing to multiple factors such as high pet population, increasing use of pet care insurance services and accessibility to advanced veterinary care products in the country. According to the North American Pet Health Insurance Association (NAPHIA), the pet health insurance in the U.S. accounted for the premiums of USD 1.99 billion in 2020, highlighting 27.5% in comparison with 2019. The pet care insurance sector has grown exponentially with around 24% annual growth rate from 2016 to 2020. As per the National Pet Owners Survey, around 67% of U.S. households own at least one pet as of 2019-2020. High pet population along with high veterinary care expenditure and availability of pet insurance in the country is promoting the demand for animal care products including animal diagnostics.

Germany held substantial revenue share in the Europe animal diagnostics market and exceeded USD 231 million in 2020 impelled by the high number of pets, favorable government initiatives and increasing incidence of several zoonotic diseases. According to the European Pet Food Industry Federation (FEDIAF), Germany accounted for around 10.7 million dogs and 15.7 million cats in 2020. Germany is one of the leading countries in terms of animal welfare initiatives and the government has implemented several regulations to bolster animal welfare such as the German Animal Welfare Law. These initiatives adopted by the government as well as public organizations such as the World Organisation for Animal Health (OIE) would further promote the demand for veterinary diagnostics. Moreover, increasing prevalence of zoonotic diseases such as Tularemia, Leptospirosis, bluetongue and hantavirus among others is expected to accelerate the industry value.

Strategic initiatives implemented by prominent players are anticipated to foster the business growth

Some of the major companies operating in the market are IDEXX Laboratories, Heska Corporation, Neogen, Zoetis, Thermo Fisher Scientific, Boehringer Ingelheim International GmbH and Virbac among others. These prominent participants focus on strategic partnerships, new product launch & commercialization for the industry expansion. Furthermore, these leaders are heavily investing in research that enables them to launch advanced products and garner maximum revenue.

Recent industry developments:

  • In June 2021, IDEXX Laboratories, Inc. announced the acquisition of rVetLink, a company that is involved in cloud-based software technology and providing referral management solutions for animal diagnostics and veterinary specialty care hospitals. This acquisition will expand the company’s portfolio of cloud technology offerings for animal diagnostics.
  • In February 2021, Heska Corporation announced the acquisition of Lacuna Diagnostics, a company that is involved in providing digital cytology services. This acquisition will allow the firm to broaden its point of care diagnostics offering.

Animal diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Technology, 2016 - 2027 (USD Million)

  • Immunodiagnostics
    • ELISA
    • Lateral Flow Assays
    • Immunoassay Analyzers
    • Others
  • Clinical Biochemistry
  • Hematology
  • Molecular Diagnostics
    • PCR
    • Microarrays
    • Others
  • Urinalysis
  • Others

Market, By Animal Type, 2016 - 2027 (USD Million)

  • Farm Animals
    • Poultry
    • Swine
    • Cattle
    • Others
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

The market for animal diagnostics surpassed USD 4.5 billion in 2020 and will expand at a strong CAGR of 8.5% from 2021 to 2027 with increasing number of pet adoption and rising cases of zoonotic diseases.
The clinical biochemistry segment was valued at around USD 1.35 billion in 2020 and will grow due to rising popularity of diagnostic and therapeutic tools to monitor disease occurrence in animals.
The companion animal segment accounted for over 60% revenue share in 2020 and will expand owing to soaring adoption of pets for companionship.
The U.S. animal diagnostics market will reach USD 3.75 billion by 2027 due to the trend for pet care insurance services and easy accessibility to advanced veterinary care products.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2020
  • Companies covered: 9
  • Tables & Figures: 355
  • Countries covered: 17
  • Pages: 225
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount